Naoko Katayama

616 total citations
19 papers, 511 citations indexed

About

Naoko Katayama is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, Naoko Katayama has authored 19 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Organic Chemistry and 4 papers in Hematology. Recurrent topics in Naoko Katayama's work include Blood Coagulation and Thrombosis Mechanisms (4 papers), Enzyme Structure and Function (4 papers) and Glycogen Storage Diseases and Myoclonus (3 papers). Naoko Katayama is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (4 papers), Enzyme Structure and Function (4 papers) and Glycogen Storage Diseases and Myoclonus (3 papers). Naoko Katayama collaborates with scholars based in Japan, United Kingdom and Canada. Naoko Katayama's co-authors include Masaya Orita, Shigeo Fujita, Hiroyuki Kurihara, Satoshi Yamamoto, Masanori Osawa, H. Kurokawa, Masatsune Kainosho, Mitsuhiko Ikura, Hiroshi Tokumitsu and Mark B. Swindells and has published in prestigious journals such as Journal of Molecular Biology, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Naoko Katayama

19 papers receiving 502 citations

Peers

Naoko Katayama
Serdar Kurtkaya United States
Raymond J. Patch United States
Laura A. Pelletier United States
René Hersperger Switzerland
Steven M. Peseckis United States
Naoko Katayama
Citations per year, relative to Naoko Katayama Naoko Katayama (= 1×) peers Ryuji Tanimura

Countries citing papers authored by Naoko Katayama

Since Specialization
Citations

This map shows the geographic impact of Naoko Katayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoko Katayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoko Katayama more than expected).

Fields of papers citing papers by Naoko Katayama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoko Katayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoko Katayama. The network helps show where Naoko Katayama may publish in the future.

Co-authorship network of co-authors of Naoko Katayama

This figure shows the co-authorship network connecting the top 25 collaborators of Naoko Katayama. A scholar is included among the top collaborators of Naoko Katayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoko Katayama. Naoko Katayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Haraguchi, Takashi, Seishi Terada, Hideki Ishizu, et al.. (2011). Coexistence of TDP‐43 and tau pathology in neurodegeneration with brain iron accumulation type 1 (NBIA‐1, formerly Hallervorden‐Spatz syndrome). Neuropathology. 31(5). 531–539. 15 indexed citations
3.
Shiraki, Ryota, Kazuhito Yokoyama, Kazuhiro Momose, et al.. (2008). Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors. Bioorganic & Medicinal Chemistry. 16(23). 10001–10012. 12 indexed citations
4.
Shiraki, Ryota, Yasuhiro Yonetoku, Kazuhiro Momose, et al.. (2008). Synthesis and pharmacological evaluation of bis-3-(3,4-dichlorophenyl)acrylamide derivatives as glycogen phosphorylase inhibitors. Bioorganic & Medicinal Chemistry. 16(18). 8627–8634. 9 indexed citations
5.
Katayama, Naoko, Masaya Orita, Tomohiko Yamaguchi, et al.. (2008). Identification of a key element for hydrogen‐bonding patterns between protein kinases and their inhibitors. Proteins Structure Function and Bioinformatics. 73(4). 795–801. 9 indexed citations
6.
Suzuki, Takayuki, Ryota Shiraki, Yasuhiro Yonetoku, et al.. (2008). Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase a. Bioorganic & Medicinal Chemistry. 16(10). 5452–5464. 21 indexed citations
7.
Ito, Kiyoshi, et al.. (2005). d-3-Hydroxybutyrate Dehydrogenase from Pseudomonas fragi: Molecular Cloning of the Enzyme Gene and Crystal Structure of the Enzyme. Journal of Molecular Biology. 355(4). 722–733. 28 indexed citations
8.
Koshio, Hiroyuki, Fukushi Hirayama, Tsukasa Ishihara, et al.. (2004). Synthesis and biological activity of novel 1,2-disubstituted benzene derivatives as factor Xa inhibitors. Bioorganic & Medicinal Chemistry. 13(4). 1305–1323. 21 indexed citations
9.
Hirayama, Fukushi, Hiroyuki Koshio, Naoko Katayama, et al.. (2003). Design, synthesis and biological activity of YM-60828 derivatives. Part 2: potent and orally-bioavailable factor Xa inhibitors based on benzothiadiazine-4-one template. Bioorganic & Medicinal Chemistry. 11(3). 367–381. 13 indexed citations
10.
Orita, Masaya, Satoshi Yamamoto, Naoko Katayama, & Shigeo Fujita. (2002). Macrophage Migration Inhibitory Factor and the Discovery of Tautomerase Inhibitors. Current Pharmaceutical Design. 8(14). 1297–1317. 54 indexed citations
11.
Hirayama, Fukushi, Hiroyuki Koshio, Naoko Katayama, et al.. (2002). The Discovery of YM-60828: A Potent, Selective and Orally-Bioavailable Factor Xa Inhibitor. Bioorganic & Medicinal Chemistry. 10(5). 1509–1523. 31 indexed citations
12.
Hirayama, Fukushi, Hiroyuki Koshio, Tsukasa Ishihara, et al.. (2002). Design, synthesis and biological activity of YM-60828 derivatives: potent and orally-Bioavailable factor Xa inhibitors based on naphthoanilide and naphthalensulfonanilide templates. Bioorganic & Medicinal Chemistry. 10(8). 2597–2610. 17 indexed citations
13.
Kurokawa, H., Masanori Osawa, Hiroyuki Kurihara, et al.. (2001). Target-induced conformational adaptation of calmodulin revealed by the crystal structure of a complex with nematode Ca2+/calmodulin-dependent kinase kinase peptide. Journal of Molecular Biology. 312(1). 59–68. 91 indexed citations
14.
Orita, Masaya, Satoshi Yamamoto, Naoko Katayama, et al.. (2000). Coumarin and Chromen-4-one Analogues as Tautomerase Inhibitors of Macrophage Migration Inhibitory Factor: Discovery and X-ray Crystallography. Journal of Medicinal Chemistry. 44(4). 540–547. 87 indexed citations
15.
Nagao, Kazuhiko, et al.. (1996). DMI-2 AND DMI-3, DNA METHYLTRANSFERASE INHIBITORS PRODUCED BY STREPTOMYCES SP. STRAIN NO. 560. Journal of enzyme inhibition. 10(2). 115–124. 6 indexed citations
16.
Suzuki, Keitarou, Kazuhiko Nagao, Jin Tokunaga, Naoko Katayama, & Masaru Uyeda. (1996). Inhibition of DNA Methyltransferase by Microbial Inhibitors and Fatty Acids. Journal of enzyme inhibition. 10(4). 271–280. 11 indexed citations
17.
Katayama, Naoko, Masayuki Kobayashi, Fumihiro Motojima, et al.. (1994). Preliminary X‐ray crystallographic studies of photosynthetic reaction center from a thermophilic sulfur bacterium, Chromatium tepidum. FEBS Letters. 348(2). 158–160. 15 indexed citations
18.
Katayama, Naoko, Masanori Iwama, Hideaki Watanabe, et al.. (1991). Comparative Base Specificity, Stability, and Lectin Activity of Two Lectins from Eggs of Rana catesbeiana and R. japonica and Liver Ribonuclease from R. catesbeiana. The Journal of Biochemistry. 109(5). 786–790. 42 indexed citations
19.
Katayama, Naoko, Masanori Iwama, Hideaki Watanabe, et al.. (1989). Primary Structure of a Ribonuclease from Bullfrog (Rana catesbeiana) Liver1. The Journal of Biochemistry. 106(5). 729–735. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026